Coagulation Analyzers

What are Coagulation Analyzers?

Coagulation analyzers, also called hemostasis analyzers, assess the proteins and cellular components involved in blood clotting. Testing covers the extrinsic pathway through prothrombin time, the intrinsic pathway through activated partial thromboplastin time, the common pathway through thrombin time, fibrinogen concentration, and fibrin degradation products such as D-dimer. Specialised tests include antithrombin, protein C and protein S, factor assays, lupus anticoagulant and heparin monitoring. The category ranges from semi-automatic single-channel instruments that an operator feeds with sample and reagent, to fully automatic random-access analyzers that load tubes, detect clot formation, and report results with quality control, and to platelet function analyzers that assess aggregation rather than plasma clotting. Laboratories choose according to test menu, daily workload, the detection principle offered, the need for reagent openness, and the required turnaround for emergency and pre-operative testing.

How do Coagulation Analyzers work?

Clot detection works on three main principles. Optical instruments measure the increase in turbidity or the change in light scatter as fibrin strands form in the cuvette, since the fibrin network scatters more light than the clear plasma. Mechanical instruments detect the change in viscosity or movement of a steel ball or magnetic particle as the clot forms, which makes them relatively insensitive to bilirubin, hemoglobin and lipemia. Chromogenic instruments add a substrate that releases a colour when a specific coagulation enzyme or inhibitor acts on it, and this is used for antithrombin, protein C and heparin assays. Immunoturbidimetric assays measure the light scattered by antigen-antibody complexes to quantify D-dimer or von Willebrand factor. Most analyzers incubate reagent at 37 degrees Celsius and start timing at reagent addition, then report the clotting time in seconds, a ratio for PT, or a concentration in derived units.

Where are Coagulation Analyzers used?

Coagulation analyzers support the diagnosis and monitoring of bleeding and clotting disorders. Routine use covers pre-operative screening, monitoring of vitamin K antagonist therapy through the international normalised ratio, monitoring of unfractionated and low molecular weight heparin, and assessment of disseminated intravascular coagulation. D-dimer testing supports the exclusion of venous thromboembolism in combination with clinical scoring. Factor assays and inhibitor tests support haemophilia diagnosis and replacement therapy monitoring, and thrombophilia testing covers antithrombin, protein C and protein S. Platelet function analyzers are used before surgery, to investigate inherited platelet disorders, and to detect resistance to antiplatelet drugs. Anticoagulation clinics, intensive care units and obstetric units are frequent users, and results are reported through the laboratory information system.

Which standards apply to Coagulation Analyzers?

Coagulation testing operates under ISO 15189 quality requirements, with method verification following CLSI H57 for coagulation testing and CLSI EP05 and EP15 for precision and verification studies. Prothrombin time results are expressed as an international normalised ratio in line with WHO thromboplastin reference standards and ISI calibration. The Clinical and Laboratory Standards Institute publishes guidelines for platelet function testing, and the International Society on Thrombosis and Haemostasis provides scientific standardisation recommendations. Electrical safety follows IEC 61010-1 and IEC 61010-2-101 for in vitro diagnostic equipment. Market registration may require CE marking under the IVD Regulation, NMPA registration in China or FDA clearance in the United States, and anticoagulant reagents also have specific labelling requirements.

How do I select the right coagulation analyzers equipment?

Choose the detection principle first, because it determines which samples can be measured reliably: mechanical and magnetic detection suits icteric, hemolyzed or lipemic samples, while optical systems are common and usually simpler to maintain. Next match the test menu to routine needs. A clinic that runs prothrombin time and activated partial thromboplastin time only can use a semi-automatic instrument with manual reagent addition, whereas a hospital laboratory reporting hundreds of samples and emergency results needs a fully automatic random-access analyzer with cap piercing, onboard reagents and STAT priority. Check whether you need chromogenic or immunoturbidimetric assays such as antithrombin and D-dimer, since not every platform supports them. Verify sample volume for pediatric tubes, the calibration and control material supply, reagent openness and lot-to-lot consistency, LIS connectivity, and the availability of application support and spare parts locally.